Kate Gerber, MD
Dermatology · Bradenton, FLNPI 1750600359
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.8%), speaking fees and education — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Incyte Corporation at 51.4% of the total. Reporting peaked in 2022 at $9,453 and has fallen 85.4% since, to $1,381 in 2025.
Across 392 payments — averaging $40.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$8K
- AbbVie$1K
- Johnson & Johnson$834
- Regeneron Healthcare Solutions, Inc.$747
- Sun Pharmaceutical Industries Inc.$677
- Novartis$528
- plus $4K from 28 others
What the payments were for
- Speaking & faculty fees$7,74048%
- Travel & lodging$560%
- Food & beverage$7,78849%
- Education$3802%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 16 | $8,206 |
| AbbVie(2 entities) | 71 | $1,291 |
| Johnson & Johnson | 59 | $834 |
| Regeneron Healthcare Solutions, Inc. | 35 | $747 |
| Sun Pharmaceutical Industries Inc. | 32 | $677 |
| Novartis | 25 | $528 |
| UCB, Inc. | 15 | $424 |
| Sanofi | 17 | $419 |
| Lilly USA, LLC | 17 | $365 |
| LEO Pharma Inc. | 14 | $337 |
| Biofrontera Inc. | 8 | $334 |
| Amgen | 13 | $311 |
| Pfizer | 11 | $224 |
| Galderma Laboratories, L.p. | 8 | $137 |
| E.r. Squibb & Sons, L.L.C. | 7 | $135 |
| Organogenesis Inc. | 5 | $132 |
| Kerecis Limited | 6 | $125 |
| Merz North America, Inc. | 4 | $113 |
| Smith+Nephew | 5 | $100 |
| Mayne Pharma Commercial LLC | 3 | $76 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $62 |
| VYNE Pharmaceuticals Inc. | 3 | $58 |
| Dermavant Sciences, Inc. | 2 | $53 |
| Convatec Inc. | 2 | $53 |
| Arcutis Biotherapeutics, Inc. | 2 | $39 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $23 |
| Aclaris Therapeutics, Inc. | 1 | $22 |
| Bristol Myers Squibb | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Journey Medical Corporation | 1 | $21 |
| Almirall LLC | 1 | $21 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $21 |
| Springworks Therapeutics, Inc. | 1 | $19 |
| Sandoz | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPZELURA$7,864
- AMELUZ$210
- BF-RhodoLED$210
- XEPI$210
How this compares
$15,964 in reported general payments places this provider in the 85th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 59 | $218,618 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $86,654 |
| Taltz AutoinjectorIxekizumab | 12 | $75,342 |
| Clobetasol Propionate | 70 | $3,420 |
| Pimecrolimus | 15 | $3,164 |
| Doxycycline Hyclate | 128 | $2,441 |
| Triamcinolone Acetonide | 175 | $2,151 |
| Metronidazole | 23 | $1,449 |
| ValacyclovirValacyclovir Hcl | 52 | $1,291 |
| Fluocinonide | 28 | $958 |
| Ketoconazole | 79 | $855 |
| Fluorouracil | 16 | $761 |
| Mupirocin | 88 | $593 |
| Cephalexin | 24 | $534 |
| Imiquimod | 21 | $482 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Bradenton
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.